Evidence map›Paper›PMID 33482851›Full record

ArticleMolecular neurodegeneration2021

Methods to investigate intrathecal adaptive immunity in neurodegeneration.

Hamilton Oh, Olivia Leventhal, Divya Channappa, Victor W Henderson, Tony Wyss-Coray, Benoit Lehallier, David Gate

Open access · goldAbstract read
In one paragraph

Article in Molecular neurodegeneration, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. IL7RBrain and behavior · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. CD4Science (New York, N.Y.) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hamilton OhDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Olivia LeventhalDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Divya ChannappaDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Victor W HendersonDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Tony Wyss-CorayDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Benoit LehallierDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
David GateDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA. dgate@stanford.edu.ORCID 0000-0003-0481-9657
Stanford University · US

Funding

Stanford Alzheimer's Disease Research CenterAdmin Supp: Developing iPSC models for AD and PDP30AG066515 · NIA · STANFORD UNIVERSITY · PI LU TIAN · 2020 to 2026
$29.0M
Working Memory in Parkinson Disease: A Cognitive & Systems Neuroscience ApproachP50AG047366 · NIA · STANFORD UNIVERSITY · PI HENDERSON, VICTOR · 2015 to 2019
$7.9M
A novel blood-CSF adaptive immune response in Alzheimer's diseaseK99NS112458 · NINDS · STANFORD UNIVERSITY · PI GATE, DAVID · 2020 to 2021
$245k
Reversing epigenetic changes in aged microglia via young circulatory factorsF32AG055255 · NIA · STANFORD UNIVERSITY · PI GATE, DAVID · 2018 to 2019
$68k
NIA NIH HHS F32 AG055255NIA NIH HHS P30 AG066515NIA NIH HHS P50 AG047366NINDS NIH HHS K99 NS112458
6 · The paper itself

Abstract

backgroundCerebrospinal fluid (CSF) provides basic mechanical and immunological protection to the brain. Historically, analysis of CSF has focused on protein changes, yet recent studies have shed light on cellular alterations. Evidence now exists for involvement of intrathecal T cells in the pathobiology of neurodegenerative diseases. However, a standardized method for long-term preservation of CSF immune cells is lacking. Further, the functional role of CSF T cells and their cognate antigens in neurodegenerative diseases are largely unknown.

resultsWe present a method for long-term cryopreservation of CSF immune cells for downstream single cell RNA and T cell receptor sequencing (scRNA-TCRseq) analysis. We observe preservation of CSF immune cells, consisting primarily of memory CD4

conclusionsHere, we provide a standardized approach for long-term storage of CSF immune cells. Additionally, we present unbiased bioinformatic approaches that will facilitate the discovery of target antigens of clonally expanded T cells in neurodegenerative diseases. These novel methods will help improve our understanding of adaptive immunity in the central nervous system.

Indexed as

Adaptive ImmunityAgedAged, 80 and overCD8-Positive T-LymphocytesCentral Nervous SystemCerebrospinal FluidFemaleHumansMaleMiddle AgedNeurodegenerative DiseasesAdaptive immunityAntigenCerebrospinal fluid cellsCSFIntrathecal cellsNeurodegenerationT cell receptor (TCR)T cells

Identifiers

PMID33482851
PMCPMC7824942
OpenAlexW3120391035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.